Inalways (5398) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.080x

Based on the latest financial reports, Inalways (5398) has a cash flow conversion efficiency ratio of 0.080x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$40.89 Million ≈ $1.29 Million USD) by net assets (NT$513.38 Million ≈ $16.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Inalways (5398) total market value for the company's overall valuation and market capitalisation.

Inalways - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Inalways's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Inalways Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Inalways ranked by their cash flow conversion efficiency. Explore how high is Inalways's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Arco Vara AS
F:AV1
-0.098x
Blackrock World Mining Trust Plc
LSE:BRWM
0.012x
Gale Pacific Ltd
AU:GAP
0.027x
NOMADAR Corp. Class A Common Stock
NASDAQ:NOMA
-0.042x
Atech OEM
TWO:6109
-0.036x
BPM Minerals Ltd
AU:BPM
-0.165x
Country Club Hospitality & Holidays Limited
NSE:CCHHL
0.014x
African Media Entertainment
JSE:AME
0.070x

Annual Cash Flow Conversion Efficiency for Inalways (2015–2025)

The table below shows the annual cash flow conversion efficiency of Inalways from 2015 to 2025. View 5398 share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$530.62 Million
≈ $16.72 Million
NT$9.14 Million
≈ $288.02K
0.017x +139.91%
2024-12-31 NT$546.17 Million
≈ $17.21 Million
NT$-23.58 Million
≈ $-742.90K
-0.043x -171.14%
2023-12-31 NT$504.59 Million
≈ $15.90 Million
NT$30.62 Million
≈ $964.76K
0.061x +246.17%
2022-12-31 NT$539.52 Million
≈ $17.00 Million
NT$-22.40 Million
≈ $-705.72K
-0.042x -122.66%
2021-12-31 NT$562.96 Million
≈ $17.74 Million
NT$103.15 Million
≈ $3.25 Million
0.183x +1710.75%
2020-12-31 NT$566.84 Million
≈ $17.86 Million
NT$-6.45 Million
≈ $-203.15K
-0.011x -147.41%
2019-12-31 NT$560.74 Million
≈ $17.67 Million
NT$13.45 Million
≈ $423.84K
0.024x +2286.81%
2018-12-31 NT$530.49 Million
≈ $16.71 Million
NT$-582.00K
≈ $-18.34K
-0.001x -100.63%
2017-12-31 NT$627.01 Million
≈ $19.75 Million
NT$108.36 Million
≈ $3.41 Million
0.173x +486.84%
2016-12-31 NT$605.72 Million
≈ $19.08 Million
NT$-27.06 Million
≈ $-852.57K
-0.045x -41.71%
2015-12-31 NT$292.23 Million
≈ $9.21 Million
NT$-9.21 Million
≈ $-290.26K
-0.032x --

About Inalways

TWO:5398 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$22.13 Million
NT$702.41 Million TWD
Market Cap Rank
#24865 Global
#1540 in Taiwan
Share Price
NT$14.20
Change (1 day)
-0.35%
52-Week Range
NT$13.95 - NT$30.65
All Time High
NT$47.05
About

Mediera Corporation manufactures electronic and power supply components in Taiwan. It is also involved in the medical biotechnology business. The company offers medicines, health food, and medical device, etc. Mediera Corporation was founded in 1967 and is based in New Taipei City, Taiwan.